Literature DB >> 4328368

Histochemically demonstrable fibre abnormalities in normal skeletal muscle and in muscle from carriers of Duchenne muscular dystrophy.

C J Morris, J A Raybould.   

Abstract

Deltoid muscle was removed at motor point biopsy from 10 female relatives of patients with Duchenne muscular dystrophy and from seven others, with no evidence of neuromuscular disease. Transverse cryostat sections of the muscle from each case were stained for reduced diphosphopyridine nucleotide diaphorase and it was found that all contained varying numbers of degenerating type 1 fibres. The percentage of abnormal fibres in the type 1 fibre population was then calculated for each case and it was found that the muscles from the patients with dystrophic relatives contained considerably higher percentages of abnormal fibres, which also showed more severe degeneration, than did the muscles from the normal cases. There was no absolute correlation between serum creatine kinase levels and degree of pathological change, though patients with the most severe changes in their muscles had abnormally high serum creatine kinase levels. It is suggested that histochemical studies could be a useful addition to the present diagnostic tests for the carrier state in Duchenne muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4328368      PMCID: PMC1083474          DOI: 10.1136/jnnp.34.3.348

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  Carrier detection in X-linked Duchenne type muscular dystrophy. A pluridimensional investigation.

Authors:  H Radu; S Migea; Z Török; L Bordeianu; A Radu
Journal:  J Neurol Sci       Date:  1968 Mar-Apr       Impact factor: 3.181

2.  Biochemical and histopathological studies of the carrier state in Duchenne's muscular dystrophy.

Authors:  V Ionasescu; O Vuia; N Luca; P Popa
Journal:  Confin Neurol       Date:  1968

3.  An assessment of the creatine kinase test in the detection of carriers of Duchenne muscular dystrophy.

Authors:  M W Thompson; E G Murphy; P J McAlpine
Journal:  J Pediatr       Date:  1967-07       Impact factor: 4.406

4.  Alkaline phosphatase-positive abnormal muscle fibers of humans.

Authors:  W K Engel; G G Cunningham
Journal:  J Histochem Cytochem       Date:  1970-01       Impact factor: 2.479

5.  Carrier detection in Duchenne muscular dystrophy. A comparative study of electron microscopy, light microscopy and serum enzymes.

Authors:  S Roy; V Dubowitz
Journal:  J Neurol Sci       Date:  1970-07       Impact factor: 3.181

6.  Changes in muscle structure in dystrophic patients, carriers and normal siblings seen by electron microscopy; correlation with levels of serum creatinephosphokinase (CPK).

Authors:  A T Milhorat; S A Shafiq; L Goldstone
Journal:  Ann N Y Acad Sci       Date:  1966-09-09       Impact factor: 5.691

7.  The Duchenne type muscular dystrophy: histopathological studies of the carrier state.

Authors:  G W Pearce; J M Pearce; J N Walton
Journal:  Brain       Date:  1966-03       Impact factor: 13.501

8.  Detection of subclinical and carrier states in Duchenne muscular dystrophy.

Authors:  H L Smith; L D Amick; W W Johnson
Journal:  J Pediatr       Date:  1966-07       Impact factor: 4.406

9.  Carrier detection in sex-linked muscular dystrophy.

Authors:  A E Emery
Journal:  J Genet Hum       Date:  1965-12

10.  Selective and nonselective susceptibility of muscle fiber types. A new approach to human neuromuscular diseases.

Authors:  W K Engel
Journal:  Arch Neurol       Date:  1970-02
View more
  2 in total

Review 1.  Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.

Authors:  H Moser
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

2.  Quantitative EMG and histological carrier detection of Duchenne muscular dystrophy.

Authors:  G Scarlato; G Valli; G Meola; L Carenini
Journal:  J Neurol       Date:  1977-11-01       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.